The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
LARP7 is a potential tumor suppressor gene in gastric cancer.
Yulan Cheng; Zhe Jin; Rachana Agarwal; Ke Ma; Jian Yang; Soibrahim Ibrahim; Alexandru V Olaru; Stefan David; Hassan Ashktorab; Duane T Smoot; et al. (Profiled Authors: Rachana Agarwal; Duane Smoot; Stephen Meltzer; Yuriko Mori; Mark Duncan; Zhe Jin; John Abraham; Alexandru Olaru)
Division of Gastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Laboratory investigation; a journal of technical methods and pathology 2012;92(7):1013-9.
We previously reported frequent truncating mutations of the RNA-binding protein gene, La ribonucleoprotein domain family, member-7 (LARP7) in gastric cancers (GCs) with frequent microsatellite instability. LARP7 negatively regulates positive transcription elongation factor-b (p-TEFb) by binding to and stabilizing 7sk RNA. p-TEFb has been linked to proliferation and de-differentiation in various tissues. Therefore, we reasoned that loss of LARP7 may contribute to gastric tumorigenesis. In this study, we evaluated LARP7 mRNA expression in 18 GCs, their corresponding non-neoplastic gastric tissues (N(GC)), and 18 normal gastric tissues from healthy individuals (N(N)). We also assessed the effects of transient small interfering (siRNA)-mediated LARP7 knockdown in immortalized non-neoplastic gastric epithelial cells. LARP7 mRNA was significantly decreased in GCs (median 2.5) relative to N(N)s (median 14.9, P<0.01) as well as relative to their corresponding N(GC)s (median 8.1, P<0.01). Transfection of an siRNA directed against LARP7 (anti-LARP7 siRNA) into non-neoplastic gastric epithelial cells decreased 7sk levels by 72% relative to a control siRNA (P<0.01). Furthermore, anti-LARP7 siRNA transfection increased cell proliferation by 23% (P<0.01) and cell migration by 22% (P<0.001) relative to control siRNA transfection. Taken together, these findings suggest that LARP7 downregulation occurs early during gastric tumorigenesis and may promote gastric tumorigenesis via p-TEFb dysregulation.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Jin Zhou; Geng Bo Chen; Yew Chung Tang; Rohit Anthony Sinha; Yonghui Wu; Chui Sun Yap; Guihua Wang; Junbo Hu; Xianmin Xia; Patrick Tan; et al.BMC medical genomics 2012;5():34.
D A Heideman; P J Snijders; E Bloemena; C J Meijer; G J Offerhaus; S G Meuwissen; W R Gerritsen; M E CraanenThe Journal of pathology 2001;194(4):428-35.
Chad A Glazer; Ian M Smith; Sheetal Bhan; Wenyue Sun; Steven S Chang; Kavita M Pattani; William Westra; Zubair Khan; Joseph A CalifanoArchives of otolaryngology--head & neck surgery 2011;137(3):286-93.
Appears in this Publication
Author of this Publication